I can only imagine the fight people will have with their insurance. One of the many reasons we can't have nice things.
I can only imagine the fight people will have with their insurance. One of the many reasons we can't have nice things.
The article explains that the substitutions increase the half-life of the substance in the body, so I understand that as an advantage of the drug over the naturally occuring peptide. This would be important with an injection. But the skeptic in me wonders if, the drug now is available in an oral form, if the real reason for pushing the drug over GLP-1 is because the drug can be patented and GLP-1 cannot.
Here are Swiss prices (German/French only): https://compendium.ch/search?q=Semaglutid
While injections are still quite expensive (~$130 per 3mg), pills are available for as little as $4 per 14mg dose (and judging from the dosage information, those pills are splittable).
I don't know the reasoning behind studying the effects of injections vs oral admission.
>The international trial was funded by the pharmaceutical company Novo Nordisk.
From the Ozempic website:
> Cornerstones4Care®, NovoFine®, and Ozempic® are registered trademarks of Novo Nordisk A/S.
Follow the money.
Realy good results and only one aplication per week, which is great.
We are from Slovenia. Drug is free of charge with normal insurance.
The EU cannot do anything against that, so why bother.
Blocking the site is something I do not understand
It looks like for two doses.